These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17765546)

  • 1. In vitro affinities of various halogenated benzamide derivatives as potential radioligands for non-invasive quantification of D(2)-like dopamine receptors.
    Stark D; Piel M; Hübner H; Gmeiner P; Gründer G; Rösch F
    Bioorg Med Chem; 2007 Nov; 15(21):6819-29. PubMed ID: 17765546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of dopamine D2-receptor selective antagonists.
    Högberg T
    Drug Des Discov; 1993; 9(3-4):333-50. PubMed ID: 8400011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands.
    Salama I; Hocke C; Utz W; Prante O; Boeckler F; Hübner H; Kuwert T; Gmeiner P
    J Med Chem; 2007 Feb; 50(3):489-500. PubMed ID: 17266201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
    Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative structure-activity relationship for some dopamine D2 antagonists of benzamide type.
    Norinder U; Högberg T
    Acta Pharm Nord; 1992; 4(2):73-8. PubMed ID: 1388772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-affinity relationships of halogenated predicentrine and glaucine derivatives at D1 and D2 dopaminergic receptors: halogenation and D1 receptor selectivity.
    Asencio M; Hurtado-Guzmán C; López JJ; Cassels BK; Protais P; Chagraoui A
    Bioorg Med Chem; 2005 Jun; 13(11):3699-704. PubMed ID: 15862999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.
    Berenguer I; El Aouad N; Andujar S; Romero V; Suvire F; Freret T; Bermejo A; Ivorra MD; Enriz RD; Boulouard M; Cabedo N; Cortes D
    Bioorg Med Chem; 2009 Jul; 17(14):4968-80. PubMed ID: 19540762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.
    Ortega R; Raviña E; Masaguer CF; Areias F; Brea J; Loza MI; López L; Selent J; Pastor M; Sanz F
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1773-8. PubMed ID: 19217777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. t-Bu2SiF-derivatized D2-receptor ligands: the first SiFA-containing small molecule radiotracers for target-specific PET-imaging.
    Iovkova-Berends L; Wängler C; Zöller T; Höfner G; Wanner KT; Rensch C; Bartenstein P; Kostikov A; Schirrmacher R; Jurkschat K; Wängler B
    Molecules; 2011 Sep; 16(9):7458-79. PubMed ID: 21892125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonist-radioligand binding to D2L-receptors in intact cells.
    Packeu A; De Backer JP; Van Liefde I; Vanderheyden PM; Vauquelin G
    Biochem Pharmacol; 2008 Jun; 75(11):2192-203. PubMed ID: 18436192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in receptor binding radiopharmaceuticals.
    Angelberger P
    Wien Klin Wochenschr; 1991; 103(15):443-50. PubMed ID: 1926870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
    Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
    Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of benzamide derivatives as TRPV1 antagonists.
    Shishido Y; Jinno M; Ikeda T; Ito F; Sudo M; Makita N; Ohta A; Iki-Taki A; Ohmi T; Kanai Y; Tamura T; Shimojo M
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1072-8. PubMed ID: 18155908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
    Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships.
    Wallinder C; Botros M; Rosenström U; Guimond MO; Beaudry H; Nyberg F; Gallo-Payet N; Hallberg A; Alterman M
    Bioorg Med Chem; 2008 Jul; 16(14):6841-9. PubMed ID: 18599297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2 and 5-HT1A receptors.
    Andrić D; Roglić G; Sukalović V; Soskić V; Kostić-Rajacić S
    Eur J Med Chem; 2008 Aug; 43(8):1696-705. PubMed ID: 18006194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
    McCormick PN; Kapur S; Seeman P; Wilson AA
    Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-Labeled FAUC 346 and BP 897 derivatives as subtype-selective potential PET radioligands for the dopamine D3 receptor.
    Hocke C; Prante O; Salama I; Hübner H; Löber S; Kuwert T; Gmeiner P
    ChemMedChem; 2008 May; 3(5):788-93. PubMed ID: 18306190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Click' D(1) receptor agonists with a 5-HT(1A) receptor pharmacophore producing D(2) receptor activity.
    Zhang J; Zhang H; Cai W; Yu L; Zhen X; Zhang A
    Bioorg Med Chem; 2009 Jul; 17(14):4873-80. PubMed ID: 19559623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.